Navigation Links
Helix BioPharma reports Q2 2008 highlights, financial results
Date:3/10/2008

y 31, 2008, the Company had cash and cash equivalents totaling $23,263,000, compared to $11,379,000 at July 31, 2007. The increase in cash and cash equivalents is the result of a private placement completed on December 19, 2007, when the Company issued 10,040,000 common shares for gross proceeds totaling $16,867,200. The total number of common shares issued as of January 31, 2008, was 46,375,335, compared to 36,335,335 in the same period last year. At January 31, 2008, the Company's working capital was $23,016,000, compared to $11,468,000 at July 31, 2007. After taking into consideration the Company's anticipated revenue, planned research and development expenditures and the assumption that there will not be unanticipated expenses, the Company expects that its current working capital will be sufficient to finance operations beyond the 2010 fiscal year.

The Company will continue to seek additional funding, primarily by way of equity offerings, to carry out its business plan and to minimize risks to its operations. The market, however, for equity financings for companies such as Helix is challenging, and there can be no assurance that additional funding by way of equity financing will be available. The failure of the Company to obtain additional funding on a timely basis may result in the Company reducing or delaying one or more of its planned research, development and marketing programs and reducing related personnel, any of which could impair the current and future value of the business. Any additional equity financing, if secured, may result in significant dilution to the existing shareholders at the time of such financing. The Company may also seek additional funding from other sources, including technology licensing, co-development collaborations and other strategic alliances, which, if obtained, may reduce the Company's interest in its projects or products. There can be no assurance, however, that any alternative sources of funding will be available.


'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015 According ... Market by Product (Equipment, Consumables), by Type (Monoclonal, Polyclonal), ... Labs, Research Institutes) - Analysis & Global Forecast ... the global Antibody Production Market for the forecast ... expected to reach $2.572 Billion by 2019 from ...
(Date:4/30/2015)... 2015   Tamir Biotechnology , a leading developer ... its Ebola antiviral therapy program. Clinical ... currently being evaluated and considered by a number of ... During the first quarter of 2015, the company participated ... The Evaluation of Potential Treatments and Vaccines For Ebola ...
(Date:4/30/2015)... Va. , April 30, 2015 Oxford ... senior debt to life sciences and healthcare services companies, ... secured term loan agreement with Celula, Inc., a diagnostic ... major diseases, enabling better patient care and improved outcomes. ... the development and expand the commercialization of its products ...
(Date:4/30/2015)... SAN DIEGO , April 30, 2015 /PRNewswire/ ... company engaged in the development of biosimilar therapeutics ... today announced the closing of its previously announced ... common stock at a public offering price of ... full by the underwriters of their option to ...
Breaking Biology Technology:Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4Oxford Finance Provides $10 Million Debt Financing to Celula 2Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2
... DEERFIELD, Ill., Dec. 3 Today, the International Society,for ... stem cell researchers, released new guidelines for the responsible,development ... A,Commentary article that summarizes the Guidelines for the ... Press in the December issue of Cell,Stem Cell, the ...
... 3 NeoStem, Inc.,(NYSE Alternext US: NBS), which is pioneering ... for future medical need,today announced that it has completed an ... priced at $1.25 per unit with each unit,consisting of one ... share of,common stock at $1.75 per share. , ...
... 3 The William Lehman Injury Research,Center ... at the, University of Miami /Jackson Medical ... and Advanced Technology Research Center (TATRC); the ... Association (ATA) and,Qualcomm, through its Wireless Reach(TM) ...
Cached Biology Technology:The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 2The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 3The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 4NeoStem Completes $500,000 Private Placement With Strategic Investor 2NeoStem Completes $500,000 Private Placement With Strategic Investor 3Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 2Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 3Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 4Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 5Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 6
(Date:4/2/2015)... 2015 Fingerprint Cards (FPC) has ... from the distributor World Peace Industrial Group (WPI), part ... although the major part of the shipments will take ... by smartphone manufacturers in China . ... the communicated revenue guidance of + 1 000 MSEK for ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... living cell needs both to build new and to ... number of intracellular systems work in concert to keep ... proteins. When proteins or peptides mutate, they can present ... environment. In Huntington's disease (HD) the disease provoking mutation ...
... international group of scientists has announced a major ... the activities of genes in living organisms. ... to describe the complex events that occur when ... Understanding these events is crucial for developing new ...
... they won't be able to understand the brain until they ... billions of neurons are interconnected. Now, researchers at the Salk ... be a major hurdle to preparing that chart: identifying all ... March 1 issue of the journal Neuron, the researchers describe ...
Cached Biology News:Proteasome activator enhances survival of Huntington's disease neuronal model cells 2Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3